Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Survey: a majority of Americans disagree with the Trump administration on birth control

The contraceptive mandate has broad support. The Trump administration’s moves to weaken it do not.

A demonstration outside the Supreme Court during a 2014 hearing on the contraceptive mandate
A demonstration outside the Supreme Court during a 2014 hearing on the contraceptive mandate
A demonstration outside the Supreme Court during a 2014 hearing on the contraceptive mandate.
The Washington Post/Contributor/Getty Images
Anna North
Anna North is a senior correspondent for Vox, where she covers American family life, work, and education. Previously, she was an editor and writer at the New York Times. She is also the author of four novels, including the forthcoming Bog Queen, which you can preorder here.

“Obamacare’s controversial contraceptive mandate.” “One of the health care law’s most controversial provisions.” “A controversial mandate in the Affordable Care Act.”

Coverage of the contraceptive mandate — the Obama-era requirement that employer health insurance cover birth control without a copay — has framed it as a contentious, hot-button issue. But a recent survey shows that birth control access has broad support among American voters — and the Trump administration’s new exemptions to the mandate are far more controversial.

In a survey of 1,058 registered voters conducted in late November by the polling firm PerryUndem, large majorities of respondents supported access to birth control as a general matter. Ninety-six percent of respondents said they supported women having access to contraception. Ninety percent said it was an important aspect of women’s ability to control their bodies, lives, and futures, and 78 percent said it was part of basic health care for women. Seventy-seven percent of those polled did not think of birth control as a controversial issue, and 90 percent said it was not a religious issue for them. Previous polling on birth control has yielded similar results; a 2016 Gallup poll, for example, found that 89 percent of Americans think contraception is morally acceptable.

A majority of respondents — 71 percent — supported the mandate that employers offer copay-free insurance for birth control. This is in line with other polling on the subject — a poll conducted by the Kaiser Family Foundation in June found that 68 percent of people, including 81 percent of Democrats, 68 percent of independents, and 54 percent of Republicans, supported the mandate.

As with abortion, the way pollsters phrase questions about birth control matters. When PerryUndem framed questions about the contraceptive mandate in terms of employers’ ability to control employees’ health care, support for the mandate went up. When asked, “do you think employers should be able to deny employees coverage for things like birth control, if they personally disagree with it,” 78 percent of respondents said no. And 82 percent of respondents said women “should be able to get birth control coverage through their health insurance” even if their bosses morally oppose contraception.

The Trump administration’s changes to the mandate, which allow any employer to seek an exemption on moral or religious grounds, were far less popular with respondents than the mandate itself. Sixty-seven percent of those polled opposed granting employers an exemption for moral reasons; 32 percent supported such exemptions. Meanwhile, 61 percent of respondents said they would be less likely to vote for an elected official who supported the moral exemption; 11 percent said they would be more likely to vote for such a candidate, and 28 percent said their votes wouldn’t change.

Reproductive health advocates have been concerned in recent months that the Trump administration may shift funding from comprehensive family planning programs to those that promote the “rhythm method” of contraception, in which a woman avoids intercourse during the most fertile part of her menstrual cycle. An internal White House “wish list” obtained by Crooked Media in October included such a funding shift.

According to Planned Parenthood, the rhythm method (also called fertility awareness) is between 76 percent and 88 percent effective, less than birth control pills or IUDs. And according to the PerryUndem survey, putting federal dollars behind programs centering on the rhythm method would be an unpopular move — 82 percent of respondents opposed promoting the rhythm method over other types of birth control.

Overall, 51 percent of respondents said the health care policies pursued by the president and Congress would negatively affect women. Twenty-seven percent said these policies would affect women both positively and negatively, and just 15 percent said women would be positively affected.

Despite its reputation for being controversial, the contraceptive mandate has been popular — and birth control access in general has even broader support. The Trump administration’s efforts to weaken the mandate, by contrast — and potential future efforts to promote less effective forms of birth control — face a lot of opposition from voters, according to PerryUndem’s data.

Some employers — like the University of Notre Dame, which recently reversed its decision to drop birth control coverage for students and employees — are still figuring out how to respond to the Trump administration’s policies on contraception. And many members of Congress and state legislators will have to address the issue as they move closer to the 2018 elections. They may find that in their communities, opposing birth control access is a losing strategy.

More in Politics

Podcasts
The Supreme Court abortion pills case, explainedThe Supreme Court abortion pills case, explained
Podcast
Podcasts

How Louisiana brought mifepristone back to SCOTUS.

By Peter Balonon-Rosen and Sean Rameswaram
Politics
Trump’s China policy is nearly the exact opposite of what everyone expectedTrump’s China policy is nearly the exact opposite of what everyone expected
Politics

As Trump heads to China, attention and resources are being shifted from Asia to yet another war in the Middle East.

By Joshua Keating
Politics
Are far-right politics just the new normal?Are far-right politics just the new normal?
Politics

Liberals are preparing for a longer war with right-wing populists than they once expected.

By Zack Beauchamp
The Logoff
Flavored vapes doomed Trump’s FDA headFlavored vapes doomed Trump’s FDA head
The Logoff

Why Marty Makary is out at the FDA, briefly explained.

By Cameron Peters
Politics
Virginia Democrats’ irresponsible new plan to save their gerrymanderVirginia Democrats’ irresponsible new plan to save their gerrymander
Politics

Democrats just handed the Supreme Court’s Republicans a loaded weapon.

By Ian Millhiser
The Logoff
Can Trump lower gas prices?Can Trump lower gas prices?
The Logoff

What suspending the gas tax would mean for you, briefly explained.

By Cameron Peters